AI In Cancer Diagnostics Market Forecast: Breaking Down The Numbers Behind Future Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
AI In Cancer Diagnostics Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The ai in cancer diagnostics market size has expanded significantly in recent years. This market is projected to grow from $0.79 billion in 2025 to $0.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.2%. The expansion observed during the historic period was influenced by factors including limited ai adoption in early diagnostic workflows, reliance on traditional imaging techniques, increasing cancer prevalence worldwide, rising demand for early detection solutions, and the expansion of diagnostic centers.
The market for AI in cancer diagnostics is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $1.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.9%. This projected growth throughout the forecast period stems from various factors, including advancements in deep learning and machine learning algorithms, the increasing prevalence of AI-powered imaging systems, greater incorporation of predictive analytics within healthcare, escalating investments in digital health technologies, and enhanced collaboration between AI innovators and medical organizations. Key trends anticipated during this period encompass the increased uptake of AI-based imaging and diagnostic instruments, the integration of predictive analytics into cancer screening processes, a growing reliance on AI for identifying and classifying tumors, the expansion of AI-driven systems for monitoring and patient follow-up, and intensified partnerships between medical facilities and AI solution providers.
Get A Free Sample Report With In-Depth Market Insights:
AI In Cancer Diagnostics Market Growth Drivers: What’s Behind The Acceleration?
The expanding occurrence of cancer is projected to fuel the advancement of artificial intelligence in the cancer diagnostics market in the future. Cancer refers to a collection of illnesses characterized by uncontrolled cell division that can invade or metastasize to other bodily regions. Incorporating AI into cancer care seeks to boost efficiency, precision, and customized treatment approaches, leading to better results for patients. For example, in May 2024, the National Cancer Institute, a US-based Government agency, reported that approximately 2 million new cancer cases are anticipated to be diagnosed in the U.S. in 2024, with more than 611,000 deaths foreseen. Furthermore, by 2040, new global cancer cases are estimated to reach 29.9 million, and cancer-related fatalities are expected to climb to 15.3 million. This growing incidence of cancer is consequently a key factor driving the expansion of artificial intelligence in the cancer diagnostics market.
AI In Cancer Diagnostics Market Segment Performance And Emerging Opportunities
The ai in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types
3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring
4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes
Subsegments:
1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software
2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices
3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services
AI In Cancer Diagnostics Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies within the AI in cancer diagnostics market are witnessing substantial expansion, driven by progress in AI-driven digital pathology solutions designed for cancer detection. These AI-powered digital pathology solutions for cancer diagnosis involve utilizing artificial intelligence (AI) algorithms to identify cancerous cells and other diagnostic indicators across various tissue samples, thereby ensuring precise and prompt cancer diagnosis, aiding in case prioritization, and delivering consistent diagnoses. For example, in November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, introduced a comprehensive End-to-End AI-powered digital pathology solution for diagnosing cancer throughout Europe. This particular solution is intended to boost accuracy, offer AI-enabled decision support tools, simplify reporting, improve laboratory performance, and strengthen diagnostic confidence.
AI In Cancer Diagnostics Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc
View The Full AI In Cancer Diagnostics Market Report:
AI In Cancer Diagnostics Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
